Your search returned 17 results.

Results
	1.	Inhibiting Fatty Acid Synthase with Omeprazole to Improve Efficacy of Neoadjuvant Chemotherapy in Patients with Operable TNBC. MedStar authors: Gallagher, Christopher Lynce, Filipa Ottaviano, Yvonne PMID: 34400413 Year: 2021 Citation: Clinical Cancer Research. 27(21):5810-5817, 2021 11 01. Institution: MedStar Franklin Square Medical Center Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Althouse SK, Ballinger TJ, Bauchle A, Dong Z, Gallagher C, Liu JY, Lynce F, Masters AR, Miller KD, Ottaviano YL, Perkins SM, Sardesai SD, Schneider BP, Storniolo AM, Stratford RE Jr, Thomas A, Zhang JT DOI: https://dx.doi.org/10.1158/1078-0432.CCR-21-0493 Add to cart (remove)
	2.	Bacitracin for Injection Recall: Impact on Immediate Breast Implant Surgical Outcomes. MedStar authors: Bekeny, Jenna Fan, Kenneth L Tefera, Eshetu A PMID: 36105366 Year: 2022 Citation: Breast Journal. 2022:1389539, 2022. Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: MedStar Georgetown University Hospital/MedStar Washington Hospital Center Plastic Surgery Residency Surgery/Plastic Surgery Medline publication type: Journal Article Form of publication: Journal Article All authors: Bekeny JC, Fan KL, Song DH, Tefera EA, Tirrell AR DOI: https://dx.doi.org/10.1155/2022/1389539 Add to cart (remove)
	3.	Pertuzumab for the treatment of breast cancer. [Review] MedStar authors: Lynce, Filipa Swain, Sandra M PMID: 24921704 Year: 2014 Citation: Cancer Investigation. 32(8):430-8, 2014 Oct. Institution: Washington Cancer Institute Medline publication type: Journal Article Research Support, Non-U.S. Gov't Review Form of publication: Journal Article All authors: Lynce F, Swain SM DOI: http://dx.doi.org/10.3109/07357907.2014.922570 Add to cart (remove)
	4.	The Role of Angiotensin-Converting Enzyme Inhibitors and beta-Blockers in Primary Prevention of Cardiac Dysfunction in Breast Cancer Patients. [Review] MedStar authors: Barac, Ana PMID: 31960742 Year: 2020 Citation: Journal of the American Heart Association. 9(2):e015327, 2020 01 21. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Barac A, Brown SA, Okwuosa TM, Volgman AS DOI: https://dx.doi.org/10.1161/JAHA.119.015327 https://dx.doi.org/10.1161/JAHA.119.015327 https://dx.doi.org/10.1161/JAHA.119.015327 https://dx.doi.org/10.1161/JAHA.119.015327 Add to cart (remove)
	5.	The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. MedStar authors: Swain, Sandra M PMID: 24885258 Year: 2014 Citation: BMC Cancer. 14:307, 2014. Institution: Washington Cancer Institute Medline publication type: Clinical Trial Journal Article Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Beattie M, Hurvitz S, Jahanzeb M, Kaufman PA, Lai C, Masaquel A, Mason G, O'Shaughnessy J, Rugo HS, Swain S, Tripathy D, Yoo B DOI: http://dx.doi.org/10.1186/1471-2407-14-307 Add to cart (remove)
	6.	Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2-Positive Breast Cancer: Analysis of the NSABP B-31 Trial. MedStar authors: Swain, Sandra M PMID: 27812689 Year: 2017 Citation: JAMA Oncology. 3(3):335-341, 2017 Mar 01 Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial Form of publication: Journal Article All authors: Bandos H, Costantino JP, Fehrenbacher L, Finnigan M, Gavin PG, Geyer CE Jr, Jeong JH, Johnson NL, Kim SR, Lipchik C, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Song N, Swain SM, Wickerham DL, Wolmark N DOI: https://dx.doi.org/10.1001/jamaoncol.2016.4884 Add to cart (remove)
	7.	Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivors. MedStar authors: Barac, Ana PMID: 30659431 Year: 2019 Citation: Breast Cancer Research & Treatment. 174(3):785-794, 2019 Apr. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Barac A, Chlebowski RT, Haque R, Shi J, Xu X DOI: https://dx.doi.org/10.1007/s10549-018-05086-8 Add to cart (remove)
	8.	Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA). MedStar authors: Swain, Sandra M PMID: 24129974 Year: 2013 Citation: Breast Cancer Research & Treatment. 142(1):89-99, 2013 Nov. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Amadori D, Baselga J, Clark E, Knott A, Miles D, Ross G, Semiglazov V, Sunpaweravong P, Swain SM DOI: http://dx.doi.org/10.1007/s10549-013-2710-z Add to cart (remove)
	9.	Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31. MedStar authors: Swain, Sandra M PMID: 24262440 Year: 2013 Citation: Journal of the National Cancer Institute. 105(23):1782-8, 2013 Dec 4. Institution: Washington Cancer Institute Medline publication type: Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Bandos H, Blackmon NL, Bohn OL, Burandt E, Costantino JP, Fehrenbacher L, Fumagalli D, Gavin PG, Geyer CE Jr, Goldstein LC, Horne ZD, Jeong JH, Kim C, Kim SI, Kim SR, Lee A, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Reilly ML, Remillard MY, Romond EH, Sneige N, Swain SM, Tanaka N, Taniyama Y, Wickerham DL, Wolmark N DOI: http://dx.doi.org/10.1093/jnci/djt321 Add to cart (remove)
	10.	Safety profile of Pertuzumab with Trastuzumab and Docetaxel in patients from Asia with human epidermal growth factor receptor 2-positive metastatic breast cancer: results from the phase III trial CLEOPATRA. MedStar authors: Swain, Sandra M PMID: 24869931 Year: 2014 Citation: Oncologist. 19(7):693-701, 2014 Jul. Institution: Washington Cancer Institute Form of publication: Journal Article All authors: Baselga J, Chan V, Clark E, Im SA, Im YH, Knott A, Miles D, Ross G, Swain SM DOI: http://dx.doi.org/10.1634/theoncologist.2014-0033 Add to cart (remove)
	11.	Avastin withdrawal symptoms. MedStar authors: Lynce, Filipa Swain, Sandra M PMID: 22263961 Citation: Expert Opinion on Pharmacotherapy. 13(3):293-8, 2012 Feb. Institution: Washington Cancer Institute Medline publication type: Editorial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Lynce F, Swain SM DOI: http://dx.doi.org/10.1517/14656566.2012.652088 Add to cart (remove)
	12.	Acquired von Willebrand disease and multiple myeloma: a case report of a breast cancer survivor. MedStar authors: Jin, Ning Nesbitt, John A Salahuddin, Farah F PMID: 24911454 Year: 2014 Citation: Blood Coagul Fibrinolysis. 25(8):890-3, 2014 Dec. Blood Coagulation & Fibrinolysis. 25(8):890-3, 2014 Dec. Institution: MedStar Union Memorial Hospital Department: Medicine Medline publication type: Case Reports Journal Article Form of publication: Journal Article All authors: Jin N, Nesbitt JA, Salahuddin FF DOI: http://dx.doi.org/10.1097/MBC.0000000000000149 Add to cart (remove)
	13.	Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer. MedStar authors: Swain, Sandra M PMID: 23868905 Year: 2013 Citation: Annals of Oncology. 24(10):2630-5, 2013 Oct. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Baselga J, Clark E, Cortes J, Im SA, Im YH, Knott A, Pivot X, Ross G, Swain SM DOI: http://dx.doi.org/10.1093/annonc/mdt274 Add to cart (remove)
	14.	Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study. MedStar authors: Swain, Sandra M PMID: 23602601 Year: 2013 Citation: Lancet Oncology. 14(6):461-71, 2013 May. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Baselga J, Benyunes MC, Campone M, Ciruelos E, Clark E, Cortes J, Ferrero JM, Kim SB, Knott A, Ro J, Ross G, Schneeweiss A, Semiglazov V, Swain SM DOI: http://dx.doi.org/10.1016/S1470-2045(13)70130-X Add to cart (remove)
	15.	Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study. MedStar authors: Asch, Federico M Barac, Ana Cunningham, A Gallagher, Christopher Hofmeyer, Mark Srichai, M B Swain, Sandra M PMID: 30852761 Year: 2019 Citation: Breast Cancer Research & Treatment. 175(3):595-603, 2019 Jun. Institution: MedStar Health MedStar Health Research Institute MedStar Heart & Vascular Institute Washington Cancer Institute Department: Associate Dean for Research Development Medline publication type: Journal Article Form of publication: Journal Article All authors: Asch FM, Barac A, Cunningham A, Dang C, Gallagher C, Geng X, Herbolsheimer P, Hofmeyer M, Isaacs C, Lynce F, Nunes R, Pohlmann PR, Shajahan-Haq A, Smith KL, Srichai MB, Swain SM, Tan MT, Timothee P, Warren R, Yu AF DOI: https://dx.doi.org/10.1007/s10549-019-05191-2 Add to cart (remove)
	16.	Bevacizumab added to neoadjuvant chemotherapy for breast cancer. MedStar authors: Swain, Sandra M PMID: 22276821 Year: 2012 Citation: New England Journal of Medicine. 366(4):310-20, 2012 Jan 26. Institution: Washington Cancer Institute Medline publication type: Journal Article Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Form of publication: Journal Article All authors: Adams PT, Atkins JN, Baez-Diaz L, Bear HD, Brufsky AM, Costantino JP, Fehrenbacher L, Gaur R, Geyer CE Jr, Gross HM, Mamounas EP, Margolese RG, Mehta RS, Rastogi P, Robidoux A, Senecal FM, Swain SM, Tang G, Wolmark N, Young JA DOI: http://dx.doi.org/10.1056/NEJMoa1111097 Add to cart (remove)
	17.	Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial. MedStar authors: Swain, Sandra M PMID: 24095300 Year: 2013 Citation: Lancet Oncology. 14(12):1183-92, 2013 Nov. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Comparative Study Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Atkins JN, Azar CA, Baez-Diaz L, Bandos H, Bear HD, Brufsky AM, Costantino JP, Farrar WB, Fehrenbacher L, Geyer CE Jr, Mamounas EP, Margolese RG, Paik S, Rastogi P, Robidoux A, Sarwar S, Shibata HR, Swain SM, Tang G, Wolmark N DOI: http://dx.doi.org/10.1016/S1470-2045(13)70411-X Add to cart (remove)

Powered by Koha